XTL Biopharmaceuticals Stock Income Statements

XTL Biopharmaceuticals Quarterly Income Statements Chart

Quarterly

Annual

Revenue

Gross Profit

Operating Profit

Net Income

XTL Biopharmaceuticals Quarterly Income Statements Table

Quarterly

Annual

Unit: USD	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2018-06-30	2017-12-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-12-31	2004-09-30	2004-06-30	2004-03-31
revenue	-459,000	1,466,000	28,000	69,000	52,000	2,152,000	29,000	-1,254,000	287,000	380,000	587,000	711,000	473,000	512,000	673,000	938,000	-3,656,000	2,000,000	1,970,000	1,970,000	247,000	226,000	114,000	114,000	113,000	114,000	114,000	114,000	294,000	295,000	1,304,000	1,304,000	862,000	864,000	359,000	864,000
cost of revenue	0	0	0	0	0	0	0	17	121,000	113,000	157,000	174,000	180,000	188,000	199,000	380,000	-1,841,000	0	0	0	-450,000	0	14,000	0	373,000	0	14,000	0	1,204,000	0	1,204,000	0	0	0	352,000	0
gross profit	-459,000	1,466,000	28,000	69,000	52,000	2,152,000	29,000	-1,254,017	166,000	267,000	430,000	537,000	293,000	324,000	474,000	558,000	-1,815,000	2,000,000	1,970,000	1,970,000	697,000	226,000	100,000	114,000	-260,000	114,000	100,000	114,000	-910,000	295,000	100,000	1,304,000	862,000	864,000	7,000	864,000
operating expenses
research and development	6,000	6,000	12,000	8,000	9,000	9,000	-4,000	145,000	43,000	40,000	50,000	38,000	32,000	25,000	18,000	24,000	552,000	2,206,000	4,262,000	0	12,553,000	0	6,445,000	0	7,641,000	0	2,588,000	0	5,473,000	0	1,840,000	0	0	0	4,363,000	0
sales, general and administrative
total operating expenses	225,000	286,000	257,000	244,000	221,000	184,000	286,000	-670,000	660,000	849,000	1,183,000	1,667,000	-536,000	1,324,000	1,397,000	1,166,000	828,000	3,359,000	5,600,000	0	16,873,000	0	7,707,000	0	11,951,000	0	3,854,000	0	10,130,000	0	2,640,000	0	-20,230,000	0	5,061,000	0
operating income	-225,000	-286,000	-257,000	-244,000	-221,000	-184,000	-286,000	-52,000	-494,000	-723,000	-753,000	-1,800,000	829,000	-1,000,000	-923,000	-608,000	709,000	-1,359,000	-3,630,000	1,970,000	-26,642,000	226,000	-7,607,000	114,000	-16,387,000	114,000	-3,754,000	114,000	-15,500,000	295,000	-2,540,000	1,304,000	-19,368,000	864,000	-5,054,000	864,000
net income	-1,301,000	2,095,000	205,000	-1,110,000	1,047,000	34,000	-2,000	-768,000	-510,000	-563,000	-686,000	-1,150,000	549,000	-1,003,000	-872,000	-296,000	801,000	-1,251,000	-3,557,000	-3,558,000	17,479,000	-6,234,000	-7,325,000	-7,325,000	-3,920,000	-3,921,000	-3,646,000	-3,646,000	-4,530,000	-4,531,000	-2,477,000	-2,477,000	-4,119,000	-4,118,000	-5,034,000	-4,118,000

We provide you with 20 years income statements for XTL Biopharmaceuticals stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of XTL Biopharmaceuticals stock. Explore the full financial landscape of XTL Biopharmaceuticals stock with our expertly curated income statements.

The information provided in this report about XTL Biopharmaceuticals stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.